Improving antiangiogenesis and anti-tumor activity of curcumin by biodegradable polymeric micelles

Biomaterials

Volumn 34, Issue 4, 2013, Pages 1413-1432

  Gong, Changyang ^a   Deng, Senyi ^a   Wu, Qinjie ^a   Xiang, Mingli ^a   Wei, Xiawei ^a   Li, Ling ^a   Gao, Xiang ^a   Wang, Bilan ^a   Sun, Lu ^a   Chen, Yishan ^a   Li, Yuchen ^a   Liu, Lei ^a   Qian, Zhiyong ^a   Wei, Yuquan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Antiangiogenesis; Biodegradable; Curcumin; Micelles; Polymer; Tumor

Indexed keywords

ANGIOGENESIS; ANTI-TUMOR ACTIVITIES; ANTIANGIOGENESIS; BIODEGRADABLE; CELLULAR UPTAKE; CURCUMIN; IN-VITRO; INHIBITORY EFFECT; MOLECULAR MODELING STUDIES; POLYMERIC MICELLE; RETENTION TIME; SOLID DISPERSION; TISSUE DISTRIBUTIONS; TRANSGENIC ZEBRAFISH; TUBE FORMATION; TUMOR GROWTH; TUMOR MODELS; TUMOR-INDUCED ANGIOGENESIS;

BIODEGRADABLE POLYMERS; BLOOD VESSELS; ORGANIC SOLVENTS; POLYMERS; TUMORS;

MICELLES;

CURCUMIN; EXCIPIENT; POLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AQUEOUS SOLUTION; ARTICLE; BLOOD VESSEL; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CRYOPROTECTION; CYTOTOXICITY; DISPERSION; DRUG EXTRAVASATION; DRUG RELEASE; ENCAPSULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG CARCINOMA; LUNG METASTASIS; LYOPHILISATE; MALE; MICELLE; MOLECULAR MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ABSORBABLE IMPLANTS; ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CURCUMIN; METABOLIC CLEARANCE RATE; MICE; MICE, INBRED C57BL; MICELLES; NANOCAPSULES; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; TISSUE DISTRIBUTION; TREATMENT OUTCOME;

DANIO RERIO;

EID: 84870310484     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.10.068     Document Type: Article

References (42)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics. CA-Cancer J Clin 2012, 2012(62):10-29.
2. Hansen S., Grabau D.A., Sφrensen F.B., Bak M., Vach W., Rose C. The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients. Clin Cancer Res 2000, 6:139-146.
3. Wu Q.J., Gong C.Y., Luo S.T., Zhang D.M., Zhang S., Shi H.S., et al. AAV-mediated human PEDF inhibits tumor growth and metastasis in murine colorectal peritoneal carcinomatosis model. BMC Cancer 2012, 12:129.
4. Wang L., Schmitz V., Perez-Mediavilla A., Izal I., Prieto J., Qian C. Suppression of angiogenesis and tumor growth by adenoviral-mediated gene transfer of pigment epithelium-derived factor. Mol Ther 2003, 8:72-79.
5. Mahtabifard A., Merritt R.E., Yamada R.E., Crystal R.G., Korst R.J. In vivo gene transfer of pigment epithelium-derived factor inhibits tumor growth in syngeneic murine models of thoracic malignancies. J Thorac Cardiov Sur 2003, 126:28-38.
6. Maheshwari R.K., Singh A.K., Gaddipati J., Srimal R.C. Multiple biological activities of curcumin: a short review. Life Sci 2006, 78:2081-2087.
7. Goel A., Kunnumakkara A.B., Aggarwal B.B. Curcumin as " Curecumin" : from kitchen to clinic. Biochem Pharmacol 2008, 75:787-809.
8. Egan M.E., Pearson M., Weiner S.A., Rajendran V., Rubin D., Glöckner-Pagel J., et al. Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 2004, 304:600-602.
9. Jagetia G.C., Aggarwal B.B. " Spicing up" of the immune system by curcumin. J Clin Immunol 2007, 27:19-35.
10. Li L., Ahmed B., Mehta K., Kurzrock R. Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer. Mol Cancer Ther 2007, 6:1276-1282.
11. Akhtar F., Rizvi M., Kar S. Oral delivery of curcumin bound to chitosan nanoparticles cured Plasmodium yoelii infected mice. Biotechnol Adv 2011, 30:310-320.
12. Yallapu M.M., Jaggi M., Chauhan S.C. Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discov Today 2012, 17:71-80.
13. Christopher L., Mack R., Daniel N., Dennis H., Sandra M., James C., et al. Dose escalation of a curcuminoid formulation. BMC Complem Altern M 2006, 6:10.
14. Safavy A., Raisch K.P., Mantena S., Sanford L.L., Sham S.W., Krishna N.R., et al. Design and development of water-Soluble curcumin conjugates as potential anticancer agents. J Med Chem 2007, 50:6284-6288.
15. Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: problems and promises. Mol Pharm 2007, 4:807-818.
16. Li L., Braiteh F.S., Kurzrock R. Liposome-encapsulated curcumin. Cancer 2005, 104:1322-1331.
17. Wagner V., Dullaart A., Bock A.-K., Zweck A. The emerging nanomedicine landscape. Nat Biotech 2006, 24:1211-1217.
18. Jain R.K., Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 2010, 7:653-664.
19. Kim B.Y.S., Rutka J.T., Chan W.C.W. Nanomedicine. New Engl J Med 2010, 363:2434-2443.
20. Farokhzad O.C., Cheng J., Teply B.A., Sherifi I., Jon S., Kantoff P.W., et al. Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci USA 2006, 103:6315-6320.
21. Hennenfent K.L., Govindan R. Novel formulations of taxanes: a review. Old wine in a new bottle?. Ann Oncol 2006, 17:735-749.
22. Gong C.Y., Wang Y.J., Wang X.H., Wei X.W., Wu Q.J., Wang B.L., et al. Biodegradable self-assembled PEG-PCL-PEG micelles for hydrophobic drug delivery, part 2: in vitro and in vivo toxicity evaluation. J Nanopart Res 2011, 13:721-731.
23. Gong C.Y., Wei X.W., Wang X.H., Wang Y.J., Guo G., Mao Y.Q., et al. Biodegradable self-assembled PEG-PCL-PEG micelles for hydrophobic honokiol delivery: I. Preparation and characterization. Nanotechnology 2010, 21:215103.
24. Gong C.Y., Wang C., Wu Q.J., Wang Y.J., Luo F., Qian Z. Efficient inhibition of colorectal peritoneal carcinomatosis by drug loaded micelles in thermosensitive hydrogel composites. Nanoscale 2012, 4. 3095-3014.
25. Fang J., Nakamura H., Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliver Rev 2011, 63:136-151.
26. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973, 52:2745-2756.
27. Gong C.Y., Shi S., Dong P.W., Kan B., Gou M.L., Wang X.H., et al. Synthesis and characterization of PEG-PCL-PEG thermosensitive hydrogel. Int J Pharm 2009, 365:89-99.
28. Gong C.-Y., Shi S., Peng X.-Y., Kan B., Yang L., Huang M.-J., et al. Biodegradable thermosensitive injectable PEG-PCL-PEG hydrogel for bFGF antigen delivery to improve humoral immunity. Growth Factors 2009, 27:377-383.
29. Jorgensen W.L., Maxwell D.S., Tirado-Rives J. Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. J Am Chem Soc 1996, 118:11225-11236.
30. Fletcher R., Reeves C. Function minimization by conjugate gradients. Comput J 1964, 7:149-154.
31. Foloppe N., MacKerell A.D. All-atom empirical force field for nucleic acids: I. Parameter optimization based on small molecule and condensed phase macromolecular target data. J Comput Chem 2000, 21:86-104.
32. Gong C.Y., Xie Y., Wu Q.J., Wang Y.J., Deng S., Xiong D., et al. Improving antitumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma. Nanoscale 2012, 4:6004-6017.
33. Timke C., Zieher H., Roth A., Hauser K., Lipson K.E., Weber K.J., et al. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy. Clin Cancer Res 2008, 14:2210-2219.
34. Butler L.M., Agus D.B., Scher H.I., Higgins B., Rose A., Cordon-Cardo C., et al. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Cancer Res 2000, 60:5165-5170.
35. Zhao C., Wang X., Zhao Y., Li Z., Lin S., Wei Y., et al. A novel xenograft model in zebrafish for high-Resolution investigating dynamics of neovascularization in tumors. PLoS ONE 2011, 6:e21768.
36. Zhao C., Yang H., Shi H., Wang X., Chen X., Yuan Y., et al. Distinct contributions of angiogenesis and vascular co-option during the initiation of primary microtumors and micrometastases. Carcinogenesis 2011, 32:1143-1150.
37. Liu J., Wei Y., Yang L., Zhao X., Tian L., Hou J., et al. Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2. Blood 2003, 102:1815-1823.
38. Ben-Sasson S.A., Sherman Y., Gavrieli Y. Identification of dying cells-in situ staining. Method Cell Biol 1995, 46:29-39.
39. Halder J., Kamat A.A., Landen C.N., Han L.Y., Lutgendorf S.K., Lin Y.G., et al. Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy. Clin Cancer Res 2006, 12:4916-4924.
40. Hoffmann J., Schirner M., Menrad A., Schneider M.R. A highly sensitive model for quantification of in vivo tumor angiogenesis induced by alginate-encapsulated tumor cells. Cancer Res 1997, 57:3847-3851.
41. Dewar M.J.S., Zoebisch E.G., Healy E.F., Stewart J.J.P. Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model. J Am Chem Soc 1985, 107:3902-3909.
42. Gou M.L., Men K., Shi H.S., Xiang M.L., Zhang J., Song J., et al. Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo. Nanoscale 2011, 3:1558-1567.